Biovex

BioVex is a privately held biotechnology company based in Woburn, Mass. where it also has an operational commercial scale manufacturing facility. The Company is developing a new class of potent biologics for the treatment of cancer and prevention of infectious disease. In addition to OncoVEX GM-CSF , the Company has a second development program, ImmunoVEX HSV2 a vaccine for genital herpes that is undergoing clinical testing in the United Kingdom.